Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-28 @ 6:14 PM
Study NCT ID:
NCT01291667
Status:
COMPLETED
Last Update Posted:
2011-02-08
First Post:
2011-02-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study for HER2-Overexpressed MBC Patients Treated by Cipterbin® Plus vinorelbinE
Sponsor:
Shanghai CP Guojian Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-05
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2011-02-06
First Submit QC Date:
None
Study First Post Date:
2011-02-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-02-07
Last Update Post Date:
2011-02-08
Last Update Post Date Type:
ESTIMATED